Delivery Order SPE2DE23D0008-SPE2D625F04S1

Award Date 11/14/24
Potential Completion Date 11/25/24
Potential Value $1.7K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Abbvie Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Irvine, CA 92612, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DE23D0008
    Indefinite Delivery Contract
  • SPE2DE23D0008-SPE2D625F04S1
    Delivery Order

This federal contract award is for the delivery of Natrelle Inspira SSM 375cc breast implants to the Medical Supply Chain, a component of the Defense Logistics Agency Troop Support. The $1,650 fixed-price delivery order with economic price adjustment was awarded to Allergan USA Inc., a subsidiary of AbbVie Inc.

Allergan USA Inc. is a prominent medical device and pharmaceutical company that specializes in surgical and aesthetic products, particularly breast implants and tissue expanders. The company has multiple federal contract vehicles, including a $13.5 million Indefinite Delivery Vehicle (IDV) with the Defense Logistics Agency Troop Support Medical for breast implants and surgical supplies, as well as a $4.9 million contract for Allergan Aesthetics surgical items and a $600,000 Blanket Purchase Agreement with the Army Medical Command for breast implants and tissue expanders.

This specific contract has no set-aside designation, reflecting Allergan's position as a sole-source provider for many of its specialized medical devices. The products are being delivered to the company's facility in Irvine, California, supporting reconstructive and aesthetic surgical procedures across federal healthcare systems, including the Department of Defense, Department of Veterans Affairs, and Indian Health Service.

Generated 2/13/25, 9:24 AM